Febrer és el Mes de la Mobilitat Assistida, una iniciativa que posa el focus en les diferents solucions existents per facilitar el desplaçament de persones amb dificultats de mobilitat i promoure una major autonomia en el dia a dia. L’objectiu és acostar a la ciutadania…
Tweet Meloni C, Marnetto F, Fagnani C, Benincasa L, Galano D, Trivedi P, Valentino P, Martire S, Di Sapio A, Bertolotto A, Repice AM, Ballerini C, Mancosu C, Frau J, Cocco E, Veroni C. EBV Dysregulation Is Associated With Immune Imbalance in Multiple Sclerosis: Evidence…
A new study suggests that how certain immune cells respond to Mavenclad (cladribine) may help explain why the treatment works well for some people with multiple sclerosis (MS), but less so for others. The researchers found that regulatory T-cells, or Tregs — immune cells that…
Teva Canada and Novartis Canada formed a partnership to ensure continued access to Mayzent (siponimod) for people in Canada living with active secondary progressive multiple sclerosis (SPMS). Teva Canada will take over the promotion, distribution, and commercialization of the oral MS therapy in Canada. The…
Tweet This is a study to determine whether you can follow instructions at home. Yep it concludes that you are big boys and girls and can follow instructions to look after you own health. Well done. Well is it surprising as people have been taking…
Tweet Lymphotoxin-dependent elevated meningeal 1 CXCL13:BAFF ratios drive grey matter injury, Nature Immunology (2026). DOI: 10.1038/s41590-025-02359-5 CXCL13 (C-X-C motif chemokine ligand 13) is a chemokine (a molecule that cells migrate towards) that acts as a B-cell attractant, guiding their movement and organizing immune responses, especially in lymphoid tissues.…
Experimental Bruton’s tyrosine kinase (BTK) inhibitors, such as tolebrutinib or evobrutinib, are as effective as the approved therapy Aubagio (teriflunomide) at preventing relapses in people with relapsing forms of multiple sclerosis (MS), according to a review of published studies. The review found the therapies to…
Years before a diagnosis of multiple sclerosis (MS), people who later develop the disease have more doctor visits and hospitalizations for sensory, nervous system, and muscle problems than people in the general population, according to a recent study. The findings support the idea of an…
Tweet Here we a have a case report of a lady who has tried a number of disease modifying treatments which were all discountinued due to lack of effect and side effects. They had been drug free for a decade and no MRI lesions but…
MSAA features the work of many talented artists affected by multiple sclerosis as part of our annual MSAA Art Showcase. Each month we share these artists’ inspiring stories and beautiful artwork with you as our Artist of the Month. This month, we celebrate Shana Stern as February’s … Continue reading → Source:…